RenovoRx Ratios (2024-2025) | RNXT

Ratios Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 52.28%63.98%80.08%
EBT Margin -1,524.87%-603.08%-1,160.53%
EBIT Margin -1,578.68%-634.60%-1,203.01%
EBITDA Margin -1,578.68%-634.60%-1,203.01%
Operating Margin -1,578.68%-634.60%-1,203.01%
Net Margin -1,524.87%-603.08%-1,160.53%
FCF Margin -1,717.26%-545.50%-853.38%
Efficiency
Assets Average 8.40M11.02M9.07M12.07M14.83M12.42M
Equity Average 5.52M8.17M5.77M8.82M11.90M9.36M
Invested Capital 1.77M9.27M7.07M4.48M13.16M10.64M8.08M
Asset Utilization Ratio 0.020.040.07
Leverage & Solvency
Equity Ratio 0.370.770.700.550.820.780.72
Valuation
Enterprise Value -4.40M-11.74M-9.60M-7.15M-14.60M-12.31M-10.04M
Return Ratios
Return on Sales -15.25%-6.03%-11.61%
Return on Assets -0.25%-0.37%-0.70%
Return on Equity -0.34%-0.47%-0.92%